BUM
Software and Device Treatment for Back and Knee Pain - with NO SIDE EFFECTS!
Company Overview
Snapshot
Founded in February 2020 by Abraham Shoshani, BUM operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its patented medical device technology.
Business overview
BUM is a medical device company specializing in orthopedic treatment for back and knee pain, offering non-surgical approaches without side effects. The company's core technology integrates mechanics, electronics, pneumatics, and software to create a device that modifies patient posture, thereby reducing pressure on the spine and knees. BUM serves the healthcare and medical devices industry, targeting individuals suffering from chronic pain and operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- What is BUM's primary focus?
- BUM is focused on developing a new orthopedic treatment for back and knee pain using a medical device that aims to provide relief without side effects.
- When was BUM founded?
- BUM was founded in February 2020.
- Who is a key founder of BUM?
- Abraham Shoshani is a founder of BUM and serves as the Director of Scientific Research and Development.
- Has BUM's technology received any approvals or patents?
- BUM's device is patented in Israel and the USA, and its technology has been approved by Prof. Meir Libergal, Head of the orthopedic branch across the Hadassah hospital conglomerate.